Popular on Amzeal
- Retrospec Appoints Nick Marvik as New Head of Growth to Lead eCommerce Expansion
- New Book Further Unravels the Myth of a "Chemical Imbalance" Causing Depression
- Connected Technologies Delivers Cutting-Edge Technology to Landmark Properties' Student Housing Communities
- AI pioneer & tech icon, Professor Chris Imafidon speaks on President Trump's $500 Billion AI project
- Enter the Dragon - PermianMuseum.com adds a Winged Dragon Fossil
- How Technology is Making the Florida Court System More Accessible
- LAIIER Closes Oversubscribed US$4M Seed Extension Funding Round, Led by Closed Loop Partners
- The Power Of Online Reviews & Why They Matter
- Osaretin Agbonavbare's AI NGO Makes History at Trump's Presidential Inauguration Ceremony
- Advanced HDR by Technicolor Enables 2024 UEFA Championship's French Broadcast in High Dynamic Range
Similar on Amzeal
- Global Digital Currency & Wealth Management Leader; Breakout 388% FY2025 Revenue Growth Over $19.7 Million: Metalpha Technology (Stock Symbol: MATH)
- Hawaii Bill Marks Progress in Protecting Patients From Dangerous Restraint Practices
- Js Art Gallery: A New International Art Space Promoting Unity Through Art
- Gold Coast Health Plan Distributes $225,000 for Fire Relief and Preparedness Efforts
- Parkbench13 Media Group Inc. Seeks Artists for Sync Licensing Opportunities
- THSYU Opens New Doors for Accredited Investors, Bridging the Gap Between Traditional Finance and the Digital Asset Frontier
- Gold Coast Health Plan Among State's Top Performers for Outstanding Health Care Quality
- NC Health Official Urges Ban on Wilderness Therapy Camps Following Child's Death
- $27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
- Performentor, LLC Announces 2025 Unleash People Energy® Award Winners
Actuated Medical President & CEO Appointed as Chair of the Industrial Advisory Board for the Penn State Center for Biodevices
Amzeal News/10585734
BELLEFONTE, Pa. - Amzeal -- Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical, has been named Chair of the Industrial Advisory Board for the Penn State Center for Biodevices. A founding member of the board since its inception in August 2020, Dr. Mulvihill brings a wealth of expertise and a strong commitment to driving innovation in the biomedical field. She will lead the board in this pivotal role during a two-year term, guiding strategic initiatives and strengthening collaboration between academia and industry.
"Collaborations between academia and the medical device industry are essential for fostering innovation and driving meaningful advancements that benefit faculty, students, and industry leaders alike. I am excited to lead the board over the next two years and am deeply committed to accelerating the center's mission of shaping the future of medical device development."
— Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO
"We are thrilled to welcome Dr. Mulvihill as the chair of our Industrial Advisory Board. Her exceptional expertise and leadership in the medical device industry, combined with her commitment to fostering innovation, will be invaluable as we continue to bridge the gap between academia and industry. We are confident that her vision and guidance will drive impactful collaborations and further our mission to advance biomedical technologies that improve lives."
More on Amzeal News
— Mary Frecker, Ph.D., Director, Penn State Center of Biodevices, Professor of Mechanical Engineering and Biomedical Engineering, Riess Chair in Engineering
The Penn State Center for Biodevices is a multidisciplinary hub dedicated to advancing innovation and collaboration in the field of biomedical devices. It brings together experts from engineering, medicine, science, and industry to address critical challenges in healthcare through cutting-edge research and development. The center fosters opportunities for faculty, students, and industry partners to collaborate on the creation of novel medical technologies, from early-stage concepts to commercialization. By providing access to state-of-the-art facilities, resources, and a collaborative network, the center aims to drive impactful solutions that improve patient care and healthcare outcomes.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 42 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on Amzeal News
About Penn State Center for Biodevices
Established in 2020, the Center for Biodevices aims to bridge foundational science and clinical applications of biodevices, while enabling success of faculty, clinicians, and students across multiple disciplines.
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
Mitotyping.com
"Collaborations between academia and the medical device industry are essential for fostering innovation and driving meaningful advancements that benefit faculty, students, and industry leaders alike. I am excited to lead the board over the next two years and am deeply committed to accelerating the center's mission of shaping the future of medical device development."
— Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO
"We are thrilled to welcome Dr. Mulvihill as the chair of our Industrial Advisory Board. Her exceptional expertise and leadership in the medical device industry, combined with her commitment to fostering innovation, will be invaluable as we continue to bridge the gap between academia and industry. We are confident that her vision and guidance will drive impactful collaborations and further our mission to advance biomedical technologies that improve lives."
More on Amzeal News
- OEM Technology Partnerships Launches Brokerage Specializing in 100+ OEM Technologies
- Cura HR's CEO, Lyssa Hansard, Featured in Forbes: Driving Meaningful Change in Pay Equity
- G2 Names OpenWater a Winter 2025 Leader in Awards and Scholarship Management
- Zezgo Rent A Car has arrived In Cyprus to Improve Car Rental Options
- Meredith Thomas Returns as Master of Ceremonies for International Women's Day Gala for 2025
— Mary Frecker, Ph.D., Director, Penn State Center of Biodevices, Professor of Mechanical Engineering and Biomedical Engineering, Riess Chair in Engineering
The Penn State Center for Biodevices is a multidisciplinary hub dedicated to advancing innovation and collaboration in the field of biomedical devices. It brings together experts from engineering, medicine, science, and industry to address critical challenges in healthcare through cutting-edge research and development. The center fosters opportunities for faculty, students, and industry partners to collaborate on the creation of novel medical technologies, from early-stage concepts to commercialization. By providing access to state-of-the-art facilities, resources, and a collaborative network, the center aims to drive impactful solutions that improve patient care and healthcare outcomes.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 42 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on Amzeal News
- Kim Estes Returns as Master of Ceremonies for International Women's Day Gala for 2025
- Andre Kay Honored with Black Excellence Award by the Florida Panthers
- Media Advisory Pastor Mark Burns to Deliver Remarks at BEYA Stars and Stripes Dinner What: The BEYA Stars and Stripes
- Wide range of dental care products at upto 40% discounted prices | DentistryDeal.com
- NaturismRE, ANF, and GNA Stand United for Naturist Rights in Australia – A Call for Global Support
About Penn State Center for Biodevices
Established in 2020, the Center for Biodevices aims to bridge foundational science and clinical applications of biodevices, while enabling success of faculty, clinicians, and students across multiple disciplines.
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
Mitotyping.com
Source: Actuated Medical, Inc.
Filed Under: Medical, Technology
0 Comments
Latest on Amzeal News
- Uhland Pop Shop Launches February 11, 2025, Bringing Local Pride to Uhland, TX
- Nova Health Labs Welcomes New Advisory Board Members to Drive Patient-Centered Innovation
- C-BATT joins NAATBatt, the premier US Battery Trade Association
- Partnerships to Launch Digital Entertainment Hub in China; $40 Million Investment into Global MOBA Digital Game Arena: NIP Group (Stock Symbol: NIPG)
- Sip Social Co. Brings Refreshing Energy to the Miami Marathon Finish Festival with FP Movement
- Igniting Souls® and EOS Worldwide® Launch EOS Impact™: The Exclusive Publishing Collaboration for 850+ EOS Implementers
- Ceramic Liberty Unveils CL8Y: A Revolutionary Deflationary Memecoin Set to Redefine DeFi
- International Women's Day Gala to Celebrate Women's Achievements and Support Fire Survivors
- Sidow Sobrino Unleashes Bite After Bite, a Captivating Music Video & Song from His 12th Studio Album, Seminal
- How New U.S. Tariffs Are Reshaping the Frequency Control & Precision Timing Industry
- L-Tron welcomes Senator Pam Helming to their Victor, NY Office
- PCnet Supports Business Growth with Reliable Managed IT Services
- New Jersey Sober Living Opens New Luxury Themed Facility in South New Jersey
- Atlanta Students to Talk with Astronauts on International Space Station
- Hawaii Bill Marks Progress in Protecting Patients From Dangerous Restraint Practices
- All me - secure anonymous social - kickstarter crowdfunding
- HomeFortis Launches Target Hardening Guides for Home Security
- Retired Leadership Facilitator Shares Decades of Wisdom in New Book
- CCG Relaunches Spring Virtual Recruitment Fair to Connect Employers with Top STEM, AI, and Veteran Talent
- The AI Revolution: How ChatGPT-Like Tools Will Transform Industries by 2030